Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Obesity (Silver Spring). 2010 May 20;19(1):171–178. doi: 10.1038/oby.2010.117

Association of Maternal Short Sleep Duration with Adiposity and Cardio-Metabolic Status at 3 Years Postpartum

Elsie M Taveras 1, Sheryl L Rifas-Shiman 1, Janet W Rich-Edwards 2, Erica P Gunderson 3, Alison M Stuebe 4, Christos S Mantzoros 5
PMCID: PMC3099421  NIHMSID: NIHMS283243  PMID: 20489690

Abstract

The purpose of this study was to examine the association of short sleep duration among women in the first year postpartum with adiposity and cardio-metabolic status at 3-years postpartum. We studied 586 women in Project Viva, a prospective cohort. At 6 months and 1 year postpartum, women reported the number of hours they slept in a 24-hour period, from which we calculated a weighted average of daily sleep. We used multivariable regression analyses to predict the independent effects of short sleep duration (≤ 5 h/d v.> 5 h/d) on adiposity, glucose metabolism, lipid metabolism, and adipokines at 3-years postpartum. Women’s mean (SD) hours of daily sleep in the first year postpartum was 6.7 (0.97) hours. After adjusting for age, race/ethnicity, education, parity, pre-pregnancy body mass index, and excessive gestational weight gain, we found that postpartum sleep ≤ 5 h/d was associated with higher postpartum weight retention (β 1.50 kg; 95% CI: 0.02, 2.86), higher subscapular + triceps skinfold thickness (β 3.94 mm; 95% CI: 1.27, 6.60) and higher waist circumference (β 3.10 cm; 95% CI: 1.25, 4.94) at 3-years postpartum. We did not observe associations of short sleep duration with measures of cardio-metabolic status at 3-years postpartum. In conclusion, short sleep duration in the first year postpartum is associated with higher adiposity at 3-years postpartum.

Keywords: Sleep, Adiposity, Cardio-Metabolic Status, Postpartum women

INTRODUCTION

Mounting epidemiologic evidence indicates that short (< 5 hrs/day) duration of sleep is a risk factor for obesity, type 2 diabetes, coronary heart disease, hypertension, and all-cause mortality in adults independent of other measured risk factors.17 The evidence that short sleep duration increases risk for obesity is strengthened by experimental studies showing altered secretion of appetite-regulating hormones in response to reductions in sleep duration.8, 9 In addition, sleep restriction has been associated with several physiologic and behavioral mechanisms that may increase risk of obesity and cardio-metabolic disorders.2

The postpartum period for women may represent a critical window for long-term weight gain and the development of obesity. Compared with weight gain during other periods of life, evidence suggests that weight retained after giving birth is associated with long-term weight gain and increased risk for becoming or remaining overweight.10 Excess weight gain associated with childbearing tends to be preferentially deposited centrally, as visceral fat, and is associated with declines in HDL cholesterol.1113 In addition, women who retain weight after pregnancy have a higher risk of complications such as impaired glucose tolerance and having a large for gestational age infant in a subsequent pregnancy, disadvantaging future offspring as well.1416 Thus, a group that may be at particularly high risk for the adverse effects of short sleep duration is women in the postpartum period.

Several published studies have reported substantial sleep restriction and reduced sleep quality in the postpartum period and a few have found insufficient sleep to be associated with women’s mental health.17, 18 In a previous study, we have also related postpartum sleep restriction to women’s physical health. We have previously shown that sleeping ≤ 5 hours/day at 6 months postpartum was strongly associated with substantial weight retention at 1 year postpartum.19 The study by Gunderson et al.19 was the first to examine postpartum sleep duration and adiposity and additionally to show that women who reduced their sleep duration from 6 months to 1 year were two times more likely to substantially retain more weight at 1 year postpartum. No existing studies have prospectively examined the effects of postpartum short sleep duration on adiposity beyond 1 year postpartum and no study has examined the effects on cardio-metabolic status. Such information would help support interventions to improve sleep quality and quantity in the postpartum period and reduce the known adverse health effects of sleep insufficiency.

The purpose of this study was to examine the longitudinal association of short sleep duration in the first year postpartum with adiposity and cardio-metabolic status at 3-years postpartum. We hypothesized that short sleep duration would be associated with higher adiposity, measured as higher body mass index (BMI), postpartum weight retention, sum of subscapular and triceps skinfold thickness, and waist circumference, an adverse cardio-metabolic state at 3 years postpartum, measured as higher insulin resistance, higher fasting levels of triglycerides, LDL cholesterol, and lower HDL cholesterol.

METHODS AND PROCEDURES

Study subjects

The subjects for this study were participants in Project Viva, a prospective cohort study of gestational factors and offspring health. 20 We recruited women who were attending their initial prenatal visit at 8 obstetrical offices of a multi-specialty group practice in Massachusetts. Eligibility criteria included fluency in English, gestational age less than 22 weeks at the initial prenatal clinical appointment, and singleton pregnancy. Details of recruitment and retention procedures are available elsewhere. 20

Of the 1579 women who were eligible for a 3-year follow-up examination; 761 of these women were eligible for the current analysis because they had not delivered another child since the birth of the index child three years previously, they did not have type 1 or type 2 diabetes, and they attended the three year visit. Of these women, 586 had complete data on sleep duration at 6 months and 1 year; 480 provided a blood sample; fasting samples were available for 147.

After obtaining informed consent, we performed in-person study visits with the mother immediately after delivery and at 6 months and 3 years postpartum. Mothers completed mailed questionnaires at 1 and 2 years postpartum. Institutional review boards of participating institutions approved the study.

Main Exposure: Maternal Postpartum Sleep Duration

At 6 months and 1 year postpartum, we asked women to report hours of sleep duration within a 24-hour period using the question: “In the past month, how many hours of sleep do you get in an average 24-hour period?”. To estimate the average number of hours that women slept from 6 months to 1 year, we summed the values for sleep duration at each time point and divided by 2.

Main Outcomes: Adiposity and Cardio-Metabolic status at three years postpartum

At 3 years postpartum, we measured women’s weight to the nearest 0.1 kg using a research quality scale, measured height to the nearest 0.1 cm using a stadiometer, waist circumference to the nearest 0.1 cm using a Lefkin woven tape, and subscapular and triceps skinfold measures to the nearest 0.1 mm using a Holtain caliper. We calculated BMI as kg/m2 and defined postpartum weight retention as the difference between measured weight at 3 years after delivery and self-reported pre-pregnancy weight.

We tested all blood samples for hemoglobin A1c, leptin, and adiponectin. We identified as fasting those participants who did not eat or drink anything other than water for 8 hours before blood samples were obtained. We tested fasting blood samples for insulin, glucose, total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. Blood samples were collected by trained phlebotomists during visits that occurred between 9am and 5pm and transferred within 24 hours for storage in liquid nitrogen freezers. Sample testing was performed at the Children’s Hospital Boston Clinical Chemistry Laboratory.

We assessed glycosylated hemoglobin using the Hitachi 917 analyzer (Roche Diagnostics, Indianapolis, IN) and calculated the %HbA1c. We calculated insulin resistance in fasting blood samples using the homeostasis model (HOMA-IR = (fasting insulin (μU/ml) × fasting glucose (mmol/L)/22.5). Fasting glucose was measured enzymatically using the Hitachi 911 analyzer. Fasting insulin was measured using a microparticle enzyme immunoassay on the IMZ analyzer (Abott Laboratories). Total cholesterol was measured enzymatically, and LDL cholesterol was assed by a homogenous direct method from Genzyme Corp, Cambridge, Mass. HDL cholesterol was assessed using a direct enzymatic colorimetric assay, and triglycerides were calculated enzymatically with correction for endogenous glycerol. We measured concentrations of leptin and adiponectin in plasma with radioimmunoassay as described previously.21, 22 Inter- and intra-assay coefficients of variation for our biosamples ranged from 2 to 10%.

Study covariates

Using a combination of self-administered questionnaires and interviews, we collected information about maternal age, education, parity, prenatal smoking (never, former, during pregnancy), household income, and race/ethnicity. We assessed maternal postpartum depression at 6 months postpartum with the Edinburgh Postpartum Depression Scale (EPDS) and dichotomized scores >=13 as depression or <13 no depression.23 Mothers reported their pre-pregnancy weight and height. We calculated gestational weight gain as the difference between the last weight prior to delivery and the self-reported pre-pregnancy weight. We categorized gestational weight gain as inadequate, adequate, or excessive for pre-pregnancy BMI categories using the new Institute of Medicine (IOM) guidelines.24 We assessed the following covariates as potential intermediates in the association between sleep duration and three-year cardio-metabolic outcomes: maternal dietary intake, physical activity, television viewing, and breastfeeding. We assessed mothers’ dietary intake on the 6-month questionnaire using the PrimeScreen, a brief food frequency questionnaire.25 PrimeScreen results were used to calculate energy-adjusted intake of total fat, trans fat, saturated fat, fiber and glycemic index. We assessed maternal physical activity (walking, moderate, and vigorous activity, hours per week) and television viewing (hours per week). At 12-months postpartum, mothers also reported their total duration of breastfeeding in months.

Statistical analysis

Our main exposure of interest was maternal short sleep duration defined as an average daily sleep duration from 6 months to 1 year ≤ 5 hours/day (v. > 5 hours/day).

We first performed univariate analyses to assess the distribution of all variables included in the analyses. We then used bivariate analyses to examine the association of our exposure of interest with study covariates and outcomes. We used multiple regression models to assess the independent effects of short sleep duration on our main outcomes. We used linear regression if the outcomes were normally distributed and median regression 26 if the distribution of the outcome was non-Gaussian. In multivariable models, we included only those covariates that were of a priori interest or confounded associations of sleep duration with our outcomes. Model 1 was unadjusted. Model 2 was adjusted for maternal age, race/ethnicity, education, parity, pre-pregnancy BMI and excessive gestational weight gain. We assessed for the possibility of multicollinearity throughout the analyses by examining standard errors when adding potentially correlated variables to models. If standard errors increased greatly, we re-evaluated the correlations and added only one of the variables. Because postpartum depression, breastfeeding duration, postpartum diet, physical activity, and TV viewing could be in the intermediate pathway between sleep and our outcomes, in Model 3 we additionally adjusted for these variables. We report regression estimates (β) and 95% confidence intervals for the main exposure. We performed data analyses with SAS version 9.2.

RESULTS

Characteristics of study participants are shown in Table 1. The mean (SD) of daily sleep duration from 6 months to 1 year was 6.7 (0.97) hours; 74 (13%) women were sleeping ≤ 5 hours/day. At 3-years postpartum, mean (SD) for BMI was 26.2 kg/m2 (6.1). Means, standard deviations, medians, and inter-quartile range of the cardio-metabolic markers that we examined are shown in Table 2.

Table 1.

Unadjusted and bivariate associations of maternal characteristics with short sleep duration from 6 months to 1 year postpartum. Data from 586 participants in Project Viva who presented for follow-up at three years postpartum without an intervening birth.

Characteristic N Overall Average Daily Sleep Duration (hrs/d), 6 Months to 1 Year Postpartum
≤ 5 hours (N = 74) > 5 hours (N = 512) p- value*
Mean (SD) or %
Sociodemographics
Maternal age at 3 years postpartum, years 586 37.7 (5.0) 38.8 (4.0) 37.6 (5.1) 0.02
Breastfeeding duration, months 586 6.2 (4.6) 6.9 (4.9) 6.1 (4.6) 0.21
Institute of Medicine gestational weight gain category
 Adequate/inadequate 259 45 44 45 0.88
 Excessive 321 55 56 55
Glucose tolerance status during pregnancy
 Normal 482 83 82 83 0.97
 Impaired glucose tolerance 76 13 14 13
 Gestational diabetes 24 4 4 4
Race/ethnicity
 White 432 74 72 74 0.07
 Black 67 11 11 12
 Hispanic 38 7 9 6
 Asian 25 4 0 5
 Other 23 4 8 3
Parity
 1 175 30 23 31 0.05
 2 276 47 43 48
 3+ 135 23 34 23
College graduate
 No 175 30 35 29 0.29
 Yes 410 70 65 71
Household income
 < $40,000/year 69 12 15 12 0.46
 ≥ $40,000/year 486 88 85 88
Smoking
 Never 406 70 70 70
 Former 123 21 19 22 0.64
 During pregnancy 48 8 11 8
Depression score at 6 months postpartum
 No, <13 505 93 81 95 <.0001
 Yes, ≥13 37 7 19 5
Diet and Physical Activity at 6 Months Postpartum
Total fat, g/d 546 34.0 (7.7) 33.8 (7.7) 34.0 (7.7) 0.85
Saturated fat, g/d 546 13.4 (3.5) 13.1 (3.9) 13.5 (3.4) 0.39
Trans fat, g/d 546 1.3 (0.59) 1.3 (0.70) 1.3 (0.57) 0.63
Glycemic index 546 281.4 (76.8) 281.9 (77.0) 281.3 (76.8) 0.95
Fiber, g/d 546 8.5 (3.0) 8.9 (3.5) 8.4 (2.9) 0.18
Walking, hrs/week 541 5.0 (4.7) 5.6 (5.6) 4.9 (4.6) 0.30
Moderate, hrs/week 537 1.3 (2.5) 1.6 (3.3) 1.2 (2.4) 0.35
Vigorous, hrs/week 541 1.1 (2.1) 0.91 (2.0) 1.1 (2.2) 0.47
Total physical activity, hrs/week 534 7.3 (7.1) 8.1 (8.5) 7.2 (6.9) 0.38
Television viewing, hrs/week 541 11.2 (8.9) 12.5 (11.4) 11.0 (8.5) 0.32
Anthropometrics
Pre-pregnancy BMI, kg/m2 586 24.8 (5.2) 25.3 (5.4) 24.8 (5.1) 0.38
BMI at 3 years postpartum, kg/m2 574 26.2 (6.1) 27.1 (6.3) 26.1 (6.1) 0.19
Postpartum weight retention at 3 years, kg 560 2.4 (5.4) 3.5 (6.4) 2.2 (5.2) 0.11
Subscapular + triceps skinfold thickness, mm 577 43.9 (15.3) 48.0 (16.4) 43.3 (15.1) 0.01
Waist circumference, cm 579 86.4 (12.4) 90.1 (14.9) 85.8 (11.9) 0.02
*

P-value from t-test for continuous and chi-square for categorical characteristics.

Energy-adjusted using the nutrient residual method.

Table 2.

Unadjusted and bivariate associations of maternal cardio-metabolic markers at 3-years postpartum with short sleep duration from 6 months to 1 year postpartum.

Cardio-Metabolic Markers at 3 Years Postpartum N* Overall Average Daily Sleep Duration (hrs/d), 6 Months to 1 Year Postpartum
≤ 5 hours > 5 hours p
Mean (SD) Median (IQR) Mean (SD) Median (IQR) Mean (SD) Median (IQR)
Hemoglobin A1c 477 5.1 (0.28) 5.1 (4.9, 5.3) 5.1 (0.29) 5.1 (4.9, 5.3) 5.1 (0.28) 5.1 (4.9, 6.6) 0.68
HOMA-IR 147 1.8 (1.9) 1.4 (0.9, 2.0) 2.0 (1.6) 1.6 (1.2, 2.2) 1.7 (1.9) 1.3 (0.9, 1.9) 0.11
Fasting insulin, u/mL 147 9.4 (7.4) 7.8 (5.3, 10.1) 10.8 (7.1) 9.1 (6.6, 10.3) 9.2 (7.4) 7.4 (5.0, 10.1) 0.17
Fasting glucose, mg/dL 147 74.6 (15.4) 77.0 (66.0, 84.0) 77.1 (17.6) 81.5 (66.0, 87.0) 74.3 (15.1) 76.0 (66.0, 83.0) 0.48
Total cholesterol, mg/dL 147 178.0 (29.9) 174.0 (158.0, 195.0) 179.1 (27.1) 173.0 (158.0, 191.0) 177.9 (30.3) 175.0 (158.0, 198.0) 0.88
LDL cholesterol, mg/dL 147 106.7 (27.8) 105.4 (90.4, 121.2) 108.6 (24.7) 106.8 (94.0, 119.2) 106.4 (28.3) 104.7 (87.8, 121.2) 0.75
HDL cholesterol, mg/dL 147 54.3 (12.1) 52.8 (45.1, 61.7) 54.0 (8.3) 55.1 (49.2, 59.8) 54.3 (12.5) 52.8 (45.1, 61.7) 0.93
Triglycerides, mg/dL 147 86.5 (45.9) 74.0 (54.0, 105.0) 80.0 (37.1) 72.5 (55.0, 105.0) 87.5 (47.1) 74.0 (54.0, 104.0) 0.68
Leptin, ng/ml 474 8.8 (6.1) 6.9 (4.2, 12.2) 10.3 (6.9) 8.5 (5.0, 14.0) 8.5 (5.9) 6.8 (4.1, 11.7) 0.07
Adiponectin, μg/ml 476 20.2 (8.7) 20.3 (14.0, 26.0) 20.4 (9.3) 20.3 (13.2, 26.0) 20.2 (8.6) 20.3 (14.1, 26.1) 0.85
*

Fasting samples were available for 147 participants.

P-value are from Fisher’s exact t-test for normally distributed variables (hemoglobin A1c, fasting glucose, total cholesterol, LDL cholesterol, HDL cholesterol, and adiponectin) and Wilcoxon rank-sum test for non-normally distributed variables (HOMA-IR, fasting insulin, triglycerides, and leptin).

In bivariate analyses, older women, multiparous mothers, and those with postpartum depression were more likely to sleep ≤ 5 hours/day. Sleep duration was not associated with breastfeeding duration, excessive gestational weight gain, or postpartum diet and physical activity (Table 1). Sleep duration ≤ 5 hours/day was associated with somewhat higher levels of leptin at 3-years postpartum (Table 2).

In multivariable analyses adjusted for maternal age, race/ethnicity, education, parity, pre-pregnancy BMI and excessive gestational weight gain, we found that postpartum sleep ≤ 5 h/d was associated with higher postpartum weight retention (β 1.50 kg; 95% CI: 0.02, 2.86), higher SS+TR thickness (β 3.94 mm; 95% CI: 1.27, 6.60) and higher waist circumference (β 3.10 cm; 95% CI: 1.25, 4.94) at 3-years postpartum (Table 3). Further adjustment for postpartum variables including postpartum depression, breastfeeding duration, diet, physical activity, and TV viewing minimally changed the observed adiposity estimates. Thus, postpartum depression, breastfeeding, diet and physical activity in the postpartum period appear to be only partial mediators of the relationship between sleep and adiposity.

Table 3.

Anthropometric measures at three-years postpartum, by average daily sleep duration from 6 months to 1 year postpartum.

Average Daily Sleep Duration (hours/day), 6 Months to 1 Year Postpartum
N ≤ 5 hours > 5 hours
Effect Estimate (95% Confidence Interval)
Body mass index (kg/m2) 574
Model 1. Unadjusted 1.02 (−0.49, 2.53) 0.00 (ref)
Model 2. Multivariable Adjusted 0.42 (−0.45, 1.30) 0.00 (ref)
Model 3. Model 2 + Postpartum Variables 0.66 (−0.25, 1.57) 0.00 (ref)
Postpartum weight retention at 3 years (kg) 560
Model 1. Unadjusted 1.27 (0.08, 2.61) 0.00 (ref)
Model 2. Multivariable Adjusted 1.50 (0.15, 2.84) 0.00 (ref)
Model 3. Model 2 + Postpartum Variables 1.44 (0.02, 2.86) 0.00 (ref)
Subscapular + Triceps Skinfold Thickness (mm) 577
Model 1. Unadjusted 4.76 (1.02, 8.49) 0.00 (ref)
Model 2. Multivariable Adjusted 3.94 (1.27, 6.60) 0.00 (ref)
Model 3. Model 2 + Postpartum Variables 4.81 (2.00, 7.62) 0.00 (ref)
Waist circumference (cm) 579
Model 1. Unadjusted 4.29 (1.27, 7.31) 0.00 (ref)
Model 2. Multivariable Adjusted 3.10 (1.25, 4.94) 0.00 (ref)
Model 3. Model 2 + Postpartum Variables 3.48 (1.55, 5.42) 0.00 (ref)

Model 2 is adjusted for maternal age, race/ethnicity, education, parity, pre-pregnancy BMI and excessive gestational weight gain. Model 3 is additionally adjusted for postpartum variables including postpartum depression, breastfeeding duration, diet, physical activity, and TV viewing.

In multivariable models, postpartum sleep ≤ 5 h/d was associated with higher HOMA-IR in unadjusted models (β 0.26; 95% CI: 0.04, 0.76). Adjustment for potential confounders strengthened the effect estimate, although confidence intervals were wide (Table 4). Further adjustment for postpartum variables did not substantially change many of our observed estimates. However, adjustment for postpartum variables appeared to have large effects on the HOMA-IR, fasting insulin, and LDL cholesterol estimates. We observed no associations of short sleep duration with other measures of glucose metabolism (hemoglobin A1c, fasting glucose), measures of lipid metabolism (total cholesterol, LDL, HDL, triglycerides) or adipokines (leptin and adiponectin) (Table 4).

Table 4.

Cardio-metabolic markers at three-years postpartum, by average daily sleep duration from 6 months to 1 year postpartum.

Average Daily Sleep Duration (hours/day), 6 Months to 1 Year Postpartum
N ≤ 5 hours > 5 hours
Effect Estimate (95% Confidence Interval)
Hemoglobin A1c 477
Model 1. Unadjusted −0.02 (−0.09, 0.06) 0.00 (ref)
Model 2. Multivariable Adjusted −0.03 (−0.10, 0.04) 0.00 (ref)
Model 3. Model 2 + Postpartum Variables −0.02 (−0.09, 0.05) 0.00 (ref)
HOMA-IR* 147
Model 1. Unadjusted 0.26 (0.04, 0.76) 0.00 (ref)
Model 2. Multivariable Adjusted 0.32 (−0.01, 0.79) 0.00 (ref)
Model 3. Model 2 + Postpartum Variables 0.09 (−0.38, 0.77) 0.00 (ref)
Fasting insulin, u/mL* 147
Model 1. Unadjusted 1.70 (−0.69, 2.36) 0.00 (ref)
Model 2. Multivariable Adjusted 1.46 (−0.87, 4.27) 0.00 (ref)
Model 3. Model 2 + Postpartum Variables 0.41 (−3.33, 2.36) 0.00 (ref)
Fasting glucose, mg/dL 147
Model 1. Unadjusted 2.75 (−4.91,10.40) 0.00 (ref)
Model 2. Multivariable Adjusted 2.48 (−5.45,10.40) 0.00 (ref)
Model 3. Model 2 + Postpartum Variables 3.13 (−4.98, 11.25) 0.00 (ref)
Total cholesterol, mg/dL 147
Model 1. Unadjusted 1.16 (−13.70,16.07) 0.00 (ref)
Model 2. Multivariable Adjusted −2.08 (−17.40, 13.21) 0.00 (ref)
Model 3. Model 2 + Postpartum Variables −6.56 (−24.20, 11.03) 0.00 (ref)
LDL cholesterol, mg/dL 147
Model 1. Unadjusted 2.21 (−11.70,16.07) 0.00 (ref)
Model 2. Multivariable Adjusted −0.16 (−14.10, 13.75) 0.00 (ref)
Model 3. Model 2 + Postpartum Variables −3.19 (−19.50, 13.16) 0.00 (ref)
HDL cholesterol, mg/dL 147
Model 1. Unadjusted −0.27 (−6.29, 5.74) 0.00 (ref)
Model 2. Multivariable Adjusted −1.56 (−7.54, 4.42) 0.00 (ref)
Model 3. Model 2 + Postpartum Variables −1.92 (−8.90, 5.05) 0.00 (ref)
Triglycerides, mg/dL* 147
Model 1. Unadjusted −1.00 (−20.90, 12.64) 0.00 (ref)
Model 2. Multivariable Adjusted −10.8 (−23.40, 15.09) 0.00 (ref)
Model 3. Model 2 + Postpartum Variables −17.2 (−31.4,0, 10.68) 0.00 (ref)
Leptin, ng/mL* 476
Model 1. Unadjusted 1.57 (−0.75, 5.47) 0.00 (ref)
Model 2. Multivariable Adjusted 1.51 (−0.14, 2.51) 0.00 (ref)
Model 3. Model 2 + Postpartum Variables 1.38 (−0.06, 2.82) 0.00 (ref)
Adiponectin, μg/mL 478
Unadjusted 0.21 (−2.04, 2.47) 0.00 (ref)
Model 1. Multivariable Adjusted 0.18 (−2.05, 2.41) 0.00 (ref)
Model 2. Model 2 + Postpartum Variables −0.59 (−2.99, 1.81) 0.00 (ref)

Model 2 is adjusted for maternal age, race/ethnicity, education, parity, pre-pregnancy BMI and excessive gestational weight gain. Model 3 is additionally adjusted for postpartum variables including postpartum depression, breastfeeding duration, diet, physical activity, and TV viewing.

*

Effect estimates for the non-normally distributed variables are from multivariable median regression. Estimates reflect the difference from the median of each outcome associated with sleep duration ≤ 5 hours/day.

DISCUSSION

In this prospective study of women, we found that short sleep duration in the first year postpartum was associated with higher adiposity independent of maternal sociodemographic characteristics. Our observed estimates were independent of pre-pregnancy BMI and excessive gestational weight gain and were not substantially influenced by postpartum depression or postpartum health behaviors including breastfeeding, diet, physical activity, and TV viewing. Short sleep duration was not associated with measures of glucose metabolism (hemoglobin A1c, fasting insulin, fasting glucose), measures of lipid metabolism (total cholesterol, LDL, HDL, triglycerides) or adipokines (leptin and adiponectin).

A large number of epidemiologic studies have shown an association between short sleep duration and adiposity, including 4 longitudinal studies 3, 2729 showing that sleep duration is associated prospectively with weight and weight change. Previous longitudinal results may not be applicable to the postpartum period because the studies focused on sleep habits over a long period of time and also because the changes in sleep during the early postpartum period have a very different origin than the origin of the changes in sleep in other published studies. Two studies have examined the relationship between sleep duration and adiposity among postpartum women. In a study by Siega-Riz et al.30, fewer hours of sleep during the night was associated with moderate or high weight retention at 3 months postpartum. The study by Gunderson et al. 19 found that sleeping ≤ 5 hours/day at 6 months postpartum was strongly associated with substantial weight retention at 1 year postpartum (adjusted odds ratio of substantial postpartum weight retention was 3.13 (95% CI: 1.42, 6.94) for sleeping ≤ 5 hours/day v. 7 hours/day).19 These studies extend research on sleep and adiposity to the postpartum period which is marked by substantial decreases in sleep duration and quality. Our adiposity findings are consistent with these previous studies and extend the results to 3-years postpartum. In this study, we found that short sleep duration was associated with higher postpartum weight retention, higher subscapular + triceps skinfold thicknesses, a measure of overall adiposity, and higher waist circumference, a measure of centrally-deposited fat. Our findings suggest that efforts to increase sleep duration among mothers in the postpartum period could prevent both short- and long-term adverse effects of short sleep duration on maternal health.

Several mechanisms have been proposed to explain the relationship between short sleep duration and adiposity, including changes in appetite regulating hormones that influence energy intake.2 Although decreases in leptin levels have been associated with acute sleep restriction in experimental studies,9 few studies have examined the longitudinal association of sleep curtailment with leptin levels. In this study, short sleep duration was not associated with leptin levels. It is possible that short sleep duration in the first year postpartum could be related to low leptin levels during the same period which could lead to increased BMI and adiposity at 3 years, but we did not have concurrent measures of leptin and sleep duration to examine this. Further prospective studies are needed to examine the association of sleep curtailment and leptin, independent of BMI and fat mass distribution.

Another proposed mechanisms relating short sleep duration to adiposity suggest that sleep curtailment may increase energy intake via influences on eating behavior. For example, in one study of normal weight adults, short sleep duration was found to be associated with increased hunger and greater desire to eat calorie-dense foods with high carbohydrate content.8 Sleep restriction may also lead to time spent in sedentary activities such as TV viewing where snacking is common.31 Finally, short sleep duration has been associated with reduced physical activity levels.2 In our study, we did not find that differences in postpartum diet, physical activity, or TV viewing explained the relationship between sleep duration and adiposity. It is still possible that short sleep duration could have led to higher energy intake by changes in eating behavior, but these were not measured in this study.

Few studies have examined the longitudinal relationship of sleep duration and biomarkers of cardio-metabolic disease. In a study of 935 women with type 2 diabetes, Williams et al. 4 found that HDL cholesterol was decreased among hypertensive women who slept ≤ 5 hours/day. Short sleep duration was not associated with other cardio-metabolic disease biomarkers, including total and LDL cholesterol and triglycerides. Consistent with the study by Williams et al., we did not find an association between short sleep duration and cardio-metabolic disease markers.

Our study had several strengths including the ability to adjust our analyses for a large number of potential sociodemographic and environmental determinants of short sleep duration including postpartum depression. We also analyzed both skinfold thicknesses as well as waist circumference, and we examined a wide range of cardio-metabolic biomarkers. Most previous studies of sleep duration and obesity have used BMI as the only obesity-related outcome and few studies have prospectively examined the full range of cardio-metabolic biomarkers we had available in this study. Our study also had limitations. First, although we had measures of total sleep duration, we did not have direct measures of sleep (i.e. from actigraphs) nor did we have measures of snoring or of other signs of obstructive sleep apnea (OSA). Thus, we are not able to determine whether our observed effects were independent of snoring and OSA, both of which have been found to be associated with adverse cardio-metabolic biomarkers.4, 32 Second, we did not have measures of sleep before or during pregnancy or beyond 1 year postpartum. Thus, it is possible that postpartum sleep is a marker of sleep at 3 years. Also, we did not measure central adiposity or cardio-metabolic biomarkers before pregnancy to control for differences in these measures that may have preceded changes in postpartum sleep. Third, our sample size for fasting insulin, glucose, and LDL cholesterol was small, and our null results can not rule out a true association. Fourth, although women in the study had diverse racial/ethnic backgrounds, their education and income levels were relatively high. Our results may not be generalizable to more socioeconomically disadvantaged populations. Finally, in any observational study it is possible that unmeasured characteristics might explain the observed associations between exposure and outcome. In particular, we did not measure total energy intake or eating behaviors which might have partially explained the observed relationship between short sleep duration and adiposity.

Conclusions

Short sleep duration in the first year postpartum is associated with higher overall and central adiposity at 3-years postpartum. Given the adverse physiological effects of central adiposity, our findings suggest that there may be significant public health impact among the sizable number of women who experience prolonged sleep curtailment in the first postpartum year.

Acknowledgments

We would like to thank the participants and research staff of Project Viva.

Funding Sources: This study was supported in part by grants from the U.S. National Institutes of Health (HD 34568, HL 64925, HL 68041, DK 053539).

Footnotes

Disclosures: The authors have no conflicts of interest to declare.

References

  • 1.Ayas NT, White DP, Al-Delaimy WK, et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care. 2003;26(2):380–384. doi: 10.2337/diacare.26.2.380. [DOI] [PubMed] [Google Scholar]
  • 2.Patel SR, Hu FB. Short sleep duration and weight gain: a systematic review. Obesity. 2008;16(3):643–653. doi: 10.1038/oby.2007.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Patel SR, Malhotra A, White DP, Gottlieb DJ, Hu FB. Association between Reduced Sleep and Weight Gain in Women. Am J Epidemiol. 2006 doi: 10.1093/aje/kwj280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Williams CJ, Hu FB, Patel SR, Mantzoros CS. Sleep duration and snoring in relation to biomarkers of cardiovascular disease risk among women with type 2 diabetes. Diabetes Care. 2007;30(5):1233–1240. doi: 10.2337/dc06-2107. [DOI] [PubMed] [Google Scholar]
  • 5.Gangwisch JE, Heymsfield SB, Boden-Albala B, et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension. 2006;47(5):833–839. doi: 10.1161/01.HYP.0000217362.34748.e0. [DOI] [PubMed] [Google Scholar]
  • 6.Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry. 2002;59(2):131–136. doi: 10.1001/archpsyc.59.2.131. [DOI] [PubMed] [Google Scholar]
  • 7.King CR, Knutson KL, Rathouz PJ, Sidney S, Liu K, Lauderdale DS. Short sleep duration and incident coronary artery calcification. JAMA. 2008;300(24):2859–2866. doi: 10.1001/jama.2008.867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004;141(11):846–850. doi: 10.7326/0003-4819-141-11-200412070-00008. [DOI] [PubMed] [Google Scholar]
  • 9.Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med. 2004;1(3):e62. doi: 10.1371/journal.pmed.0010062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Rosenberg L, Palmer JR, Wise LA, Horton NJ, Kumanyika SK, Adams-Campbell LL. A prospective study of the effect of childbearing on weight gain in African-American women. Obes Res. 2003;11(12):1526–1535. doi: 10.1038/oby.2003.204. [DOI] [PubMed] [Google Scholar]
  • 11.Gunderson EP, Lewis CE, Murtaugh MA, Quesenberry CP, Smith West D, Sidney S. Long-term plasma lipid changes associated with a first birth: the Coronary Artery Risk Development in Young Adults study. Am J Epidemiol. 2004;159(11):1028–1039. doi: 10.1093/aje/kwh146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Gunderson EP, Murtaugh MA, Lewis CE, Quesenberry CP, West DS, Sidney S. Excess gains in weight and waist circumference associated with childbearing: The Coronary Artery Risk Development in Young Adults Study (CARDIA) Int J Obes Relat Metab Disord. 2004;28(4):525–535. doi: 10.1038/sj.ijo.0802551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Gunderson EP, Sternfeld B, Wellons MF, et al. Childbearing may increase visceral adipose tissue independent of overall increase in body fat. Obesity (Silver Spring) 2008;16(5):1078–1084. doi: 10.1038/oby.2008.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Pole JD, Dodds LA. Maternal outcomes associated with weight change between pregnancies. Can J Public Health. 1999;90(4):233–236. doi: 10.1007/BF03404122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Villamor E, Cnattingius S. Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study. Lancet. 2006;368(9542):1164–1170. doi: 10.1016/S0140-6736(06)69473-7. [DOI] [PubMed] [Google Scholar]
  • 16.Ohlin A, Rossner S. Factors related to body weight changes during and after pregnancy: the Stockholm Pregnancy and Weight Development Study. Obes Res. 1996;4(3):271–276. doi: 10.1002/j.1550-8528.1996.tb00545.x. [DOI] [PubMed] [Google Scholar]
  • 17.Lee KA, Zaffke ME, McEnany G. Parity and sleep patterns during and after pregnancy. Obstet Gynecol. 2000;95(1):14–18. doi: 10.1016/s0029-7844(99)00486-x. [DOI] [PubMed] [Google Scholar]
  • 18.Wolfson AR, Crowley SJ, Anwer U, Bassett JL. Changes in sleep patterns and depressive symptoms in first-time mothers: last trimester to 1-year postpartum. Behav Sleep Med. 2003;1(1):54–67. doi: 10.1207/S15402010BSM0101_6. [DOI] [PubMed] [Google Scholar]
  • 19.Gunderson EP, Rifas-Shiman SL, Oken E, et al. Association of fewer hours of sleep at 6 months postpartum with substantial weight retention at 1 year postpartum. Am J Epidemiol. 2008;167(2):178–187. doi: 10.1093/aje/kwm298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Gillman MW, Rich-Edwards JW, Rifas-Shiman SL, Lieberman ES, Kleinman KP, Lipshultz SE. Maternal age and other predictors of newborn blood pressure. J Pediatr. 2004;144:240–245. doi: 10.1016/j.jpeds.2003.10.064. [DOI] [PubMed] [Google Scholar]
  • 21.Jimerson DC, Mantzoros C, Wolfe BE, Metzger ED. Decreased Serum Leptin in Bulimia Nervosa. J Clin Endocrinol Metab. 2000;85(12):4511–4514. doi: 10.1210/jcem.85.12.7051. [DOI] [PubMed] [Google Scholar]
  • 22.Gavrila A, Chan JL, Yiannakouris N, et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab. 2003;88:4823–4831. doi: 10.1210/jc.2003-030214. [DOI] [PubMed] [Google Scholar]
  • 23.Cox JL, Chapman G, Murray D, Jones P. Validation of the Edinburgh Postnatal Depression Scale (EPDS) in non-postnatal women. J Affect Disord. 1996;39(3):185–189. doi: 10.1016/0165-0327(96)00008-0. [DOI] [PubMed] [Google Scholar]
  • 24.Committee to Reexamine IOM Pregnancy Weight Guidelines. Weight Gain During Pregnancy: Reexamining the Guidelines. Washington, DC: Institute of Medicine, National Research Council, The National Academies Press; 2009. [Google Scholar]
  • 25.Rifas-Shiman SL, Willett WC, Lobb R, Kotch J, Dart C, Gillman MW. PrimeScreen, a brief dietary screening tool: reproducibility and comparability with both a longer food frequency questionnaire and biomarkers. Public Health Nutr. 2001;(4):249–254. doi: 10.1079/phn200061. [DOI] [PubMed] [Google Scholar]
  • 26.Gould WW, Rogers WH. American Statistical Association. Quantile regression as an alternative to robust regression. Proceedings of the Statistical Computing Section; Alexandria, VA. 1994. [Google Scholar]
  • 27.Chaput JP, Despres JP, Bouchard C, Tremblay A. The association between sleep duration and weight gain in adults: a 6-year prospective study from the Quebec Family Study. Sleep. 2008;31(4):517–523. doi: 10.1093/sleep/31.4.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield SB. Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep. 2005;28(10):1289–1296. doi: 10.1093/sleep/28.10.1289. [DOI] [PubMed] [Google Scholar]
  • 29.Hasler G, Buysse DJ, Klaghofer R, et al. The association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep. 2004;27(4):661–666. doi: 10.1093/sleep/27.4.661. [DOI] [PubMed] [Google Scholar]
  • 30.Siega-Riz AM, Herring AH, Carrier K, Evenson KR, Dole N, Deierlein A. Sociodemographic, Perinatal, Behavioral, and Psychosocial Predictors of Weight Retention at 3 and 12 Months Postpartum. Obesity (Silver Spring) 2009 Dec 24; doi: 10.1038/oby.2009.458. [Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Sivak M. Sleeping more as a way to lose weight. Obes Rev. 2006;7(3):295–296. doi: 10.1111/j.1467-789X.2006.00262.x. [DOI] [PubMed] [Google Scholar]
  • 32.Newman AB, Nieto FJ, Guidry U, et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol. 2001;154(1):50–59. doi: 10.1093/aje/154.1.50. [DOI] [PubMed] [Google Scholar]

RESOURCES